Table 2.
Characteristics of 5,502 White non-Hispanic Invasive Cases and Controls
| MAY | NCO | MAL | SEA | STA | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Case (N=287) |
Control (N=462) |
Case (N=382) |
Control (N=479) |
Case (N=447) |
Control (N=1,221) |
Case (N=717) |
Control (N=852) |
Case (N=287) |
Control (N=368) |
|
| Age | ||||||||||
| Mean (SD) | 61.6 (12.5) | 60.0 (13.0) | 56.8 (10.7) | 54.8 (12.0) | 59.9 (10.6) | 56.8 (11.5) | 55.7 (10.0) | 52.7 (8.3) | 51.2 (8.7) | 48.3 (10.3) |
| Age Quartile, years | ||||||||||
| <=46 | 30 (11%) | 69 (15%) | 68 (18%) | 123 (26%) | 53 (12%) | 243 (20%) | 112 (16%) | 202 (24%) | 82 (29%) | 137 (37%) |
| 47–53 | 52 (18%) | 78 (17%) | 82 (22%) | 118 (25%) | 83 (19%) | 293 (24%) | 178 (25%) | 323 (38%) | 76 (27%) | 105 (29%) |
| 54–62 | 70 (24%) | 113 (25%) | 108 (28%) | 80 (17%) | 114 (26%) | 247 (20%) | 236 (33%) | 205 (24%) | 110 (38%) | 104 (28%) |
| 63+ | 135 (47%) | 202 (44%) | 124 (33%) | 158 (33%) | 197 (44%) | 438 (36%) | 191 (27%) | 122 (14%) | 19 (7%) | 22 (6%) |
| Age Menarche | ||||||||||
| Mean (SD) | 12.8 (1.53) | 13.2 (4.47) | 12.5 (1.45) | 12.7 (1.41) | 13.6 (1.69) | 13.6 (1.63) | 12.9 (1.95) | 12.9 (1.52) | 12.5 (1.44) | 12.8 (1.54) |
| Menopause Status | ||||||||||
| Pre/Peri | 70 (24%) | 108 (23%) | 73 (19%) | 154 (32%) | 74 (17%) | 373 (31%) | 240 (34%) | 557 (65%) | 14 (5%) | 182 (50%) |
| Post | 209 (73%) | 327 (71%) | 273 (72%) | 316 (66%) | 280 (63%) | 848 (70%) | 414 (58%) | 294 (35%) | 147 (51%) | 129 (35%) |
| Unknown | 8 (3%) | 27 (5.9%) | 36 (9%) | 9 (2%) | 93 (21%) | 0 (0%) | 63 (9%) | 1 (<1%) | 126 (44%) | 57 (16%) |
| Ever used OC | ||||||||||
| Yes | 133 (46%) | 261 (57%) | 240 (63%) | 328 (69%) | 146 (33%) | 686 (56%) | 297 (41%) | 580 (68%) | 209 (73%) | 311 (85%) |
| No | 139 (48%) | 164 (36%) | 131 (34%) | 147 (31%) | 207 (46%) | 535 (44%) | 399 (56%) | 271 (32%) | 76 (27%) | 55 (15%) |
| Unknown | 15 (5%) | 37 (8%) | 11 (3%) | 4 (<1%) | 94 (21%) | 0 (0%) | 21 (3%) | 1 (<1%) | 2 (<1%) | 2 (<1%) |
| Number of Live Births | ||||||||||
| 0 | 47 (16%) | 64 (14%) | 77 (20%) | 62 (13%) | 54 (12%) | 72 (6%) | 117 (16%) | 111 (13%) | 70 (24%) | 59 (16%) |
| 1–2 | 97 (34%) | 153 (33%) | 185 (48%) | 268 (56%) | 157 (35%) | 510 (42%) | 343 (48%) | 387 (45%) | 111 (39%) | 156 (42%) |
| 3+ | 137 (48%) | 218 (47%) | 116 (31%) | 149 (31%) | 143 (32%) | 639 (52%) | 223 (31%) | 353 (4%) | 106 (37%) | 151 (41%) |
| Unknown | 6 (2%) | 27 (6%) | 4 (1%) | 0 (0%) | 93 (21%) | 0 (0%) | 34 (5%) | 1 (0.1%) | 0 (0%) | 2 (<1%) |
| Histology | ||||||||||
| Serous | 168 (59%) | n.a. | 234 (61%) | n.a. | 275 (62%) | n.a. | 254 (35%) | n.a. | 159 (55%) | n.a. |
| Endometrioid | 58 (20%) | n.a. | 58 (15%) | n.a. | 56 (13%) | n.a. | 129 (18%) | n.a. | 44 (15%) | n.a. |
| Mucinous | 9 (3%) | n.a. | 22 (6%) | n.a. | 43 (10%) | n.a. | 97 (14%) | n.a. | 24 (8%) | n.a. |
| Clear Cell | 18 (6%) | n.a. | 32 (8%) | n.a. | 33 (7%) | n.a. | 62 (9%) | n.a. | 22 (8%) | n.a. |
| Other/Unknown Epithelial* | 43 (15%) | n.a. | 67 (18%) | n.a. | 40 (9%) | n.a. | 175 (24%) | n.a. | 38 (13%) | n.a. |
Values are presented as number (percent) unless otherwise indicated.
*
Includes papillary, undifferentiated, mixed histologies, and other unknown epithelial adenocarcinomas.